N/A
Manufactured by Schwabe North America
71 FDA adverse event reports analyzed
Last updated: 2026-04-15
PELARGONIUM SIDOIDES is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Schwabe North America. The most commonly reported adverse reactions for PELARGONIUM SIDOIDES include ASTHENIA, BLOOD PRESSURE INCREASED, DIZZINESS, DRUG DEPENDENCE, DRUG-INDUCED LIVER INJURY. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for PELARGONIUM SIDOIDES.
Out of 22 classified reports for PELARGONIUM SIDOIDES:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 71 FDA FAERS reports that mention PELARGONIUM SIDOIDES. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include ASTHENIA, BLOOD PRESSURE INCREASED, DIZZINESS, DRUG DEPENDENCE, DRUG-INDUCED LIVER INJURY, HEPATOTOXICITY. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Schwabe North America in connection with PELARGONIUM SIDOIDES. Always verify the specific product and NDC with your pharmacist.